Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A shot of good cholesterol: synthetic HDL, a new intervention for atherosclerosis.

The Journal of cardiovascular nursing - 1 Jan 2000

Dudley-Brown Sharon

Abstract excerpt

One of the American Heart Association's Top 10 Research Advances for the Treatment of Heart Disease is the use of a synthetic form of high-density lipoprotein (HDL) to reduce coronary atherosclerosis (JAMA. 2003;290:2292-2300). While HDL has not been a target for therapy for dyslipidemias, new in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoprotein A-I
Share to Arteriosclerosis
Share to Cholesterol, LDL

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hyperlipidemias

Share to Practice Guidelines as Topic

Share to Predictive Value of Tests

Share to Treatment Outcome

Source

Identifiers

PMID: 15529065
DOI: 10.1097/00005082-200411000-00015

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-15529065-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

A shot of good cholesterol: synthetic HDL, a new intervention for atherosclerosis.PMID 15529065Read ↗

Leveraging knowledge of HDLs major protein ApoA1: Structure, function, mutations, and potential therapeutics.Semantic proximity Read ↗

Advances in the Study of the Antiatherogenic Function and Novel Therapies for HDLSemantic proximity Read ↗

Raising high-density lipoprotein cholesterol: innovative strategies against an old adversary.Semantic proximity Read ↗

Quo Vadis after AEGIS: New Opportunities for Therapies Targeted at Reverse Cholesterol Transport?Semantic proximity Read ↗

New drug fizzles at raising HDL. Tried-and-true strategies are still excellent ways to boost good cholesterol.Semantic proximity Read ↗

Modifications of the 22A apoA-I mimetic peptide sequence improve the anti-atherosclerotic properties of synthetic HDLSemantic proximity Read ↗

Apolipoprotein A-I(Milano): current perspectives.Semantic proximity Read ↗

Enhanced HDL Functionality in Small HDL Species Produced Upon Remodeling of HDL by Reconstituted HDL, CSL112Semantic proximity Read ↗

HDL Is Not Dead YetSemantic proximity Read ↗

Apolipoprotein A-I(Milano) and apolipoprotein A-I(Paris) exhibit an antioxidant activity distinct from that of wild-type apolipoprotein A-I.Semantic proximity Read ↗

The replacement of arginine by cysteine at residue 151 in apolipoprotein A-I produces a phenotype similar to that of apolipoprotein A-IMilano.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.